Halozyme Therapeutics, Inc.

HALO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 8, 2026 FORM 4
4/A Oct 8, 2026 FORM 4/A
4 Oct 2, 2026 FORM 4
3 Oct 2, 2026 FORM 3
4 Oct 2, 2026 FORM 4
8-K Sep 30, 2026 8-K
8-K Sep 22, 2026 8-K
8-K Sep 18, 2026 8-K
4 Sep 17, 2026 FORM 4
144 Sep 16, 2026
8-K Sep 16, 2026 8-K
4 Sep 11, 2026 FORM 4
4 Sep 2, 2026 FORM 4
3 Aug 21, 2026 FORM 3
4 Aug 19, 2026 FORM 4
8-K Aug 18, 2026 8-K
144 Aug 17, 2026
144 Aug 11, 2026
4 Aug 11, 2026 FORM 4
144 Aug 10, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jul 9, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
← Newer Page 1 of 61 · 1516 filings Older →